Partial Nephrectomy as Treatment of an Atypical Metastasis from Prostate Cancer—A Case Report and Review of Literature
- 1 Department of Urology, Lagoa Federal Hospital, Rio de Janeiro, Brazil
- 2 Department of Urology, Lagoa Federal Hospital, Rio de Janeiro, Brazil
- 3 Department of Urology, Lagoa Federal Hospital, Rio de Janeiro, Brazil
- 4 Department of Urology, Lagoa Federal Hospital, Rio de Janeiro, Brazil
- 5 Department of Urology, Lagoa Federal Hospital, Rio de Janeiro, Brazil
- 6 Department of Urology, Lagoa Federal Hospital, Rio de Janeiro, Brazil
Abstract
Background: Prostate cancer is the second most common type of cancer in man and the second in cancer-specific deaths in this population in the world. Most of the causes of death related to prostate cancer are due to its distant metastases, with the most common sites being: skeleton, distant lymph nodes, liver and lung. Renal metastasis is rare, and studies suggest infiltration due to arterial microembolization of the tumor. A key point in this scenario is the clinical suspicion of differential diagnoses, to offer the patient an effective therapy in such a specific case. Aim: To report a case of a patient with prostate cancer undergoing partial nephrectomy whose histopathological report revealed a metastatic lesion of that primary site. Case Presentation: 74 years old man, referred in May 2015 due to high PSA level and lumbago. PSA 323.11 ng/dl, rectal examination cT3a; biopsy was performed and histopathological study reported bilateral prostate adenocarcinoma, Gleason’s score 8 (4 + 4). Patient’s staging showed multiple secondary implants on skeletal scintigraphy. Tomography revealed solid exophytic lesion in the lower pole of the right kidney (4.7 × 3.6 cm); prostate without cleavage planes with seminal vesicles and pelvic node enlargement. Hormone therapy was initiated, PSA levels dropped to 9.51 ng/dl and total testosterone < 50 ng/dl. Partial nephrectomy was planned, initially by laparoscopy, but converted to laparotomy in December 2015. Procedure lasting 3 hours, minimal blood loss, no perioperative complications, discharged on the 3rd postoperative day. Histopathological report described undifferentiated malignant neoplasm, requiring immunohistochemistry that confirmed prostate adenocarcinoma. Patient remains hormone therapy, with no progression of the disease so far. Conclusion: Given the rarity of these cases, it is not possible to presume that nephrectomy enhances the survival rates. However, we observed that partial nephrectomy was a good choice for our patient, being the first case described in the literature. More reports should be available and studies with higher levels of evidence should be conducted to assist us in patient orientation and decision making.
- Mottet, N., Bellmunt, J., Bolla, M., Briers, E., Cumberbatch, M.G., De Santis, M., et al. (2017) EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology, 71, 618-629. https://doi.org/10.1016/j.eururo.2016.08.003
- Scosyrev, E., Messing, E.M., Mohile, S., Golijanin, D. and Wu, G. (2012) Prostate Cancer in the Elderly: Frequency of Advanced Disease at Presentation and Disease-Specific Mortality. Cancer, 118, 3062-3070. https://doi.org/10.1002/cncr.26392
- Wein, A.J., Kavoussi, L.R., Novick, A.C., Partin, A.W. and Peters, C.A. (2011) Campbell-Walsh Urology: Expert Consult Premium Edition: Enhanced Online Features and Print, 4-Volume Set. Elsevier Health Sciences, Philadelphia, 2729 p.
- Khan, F., Mahmalji, W., Sriprasad, S. and Madaan, S. (2013) Prostate Cancer with Metastases to the Kidney: A Rare Manifestation of a Common Disease. BMJ Case Reports, 2013, Article ID: bcr2012008388. https://doi.org/10.1136/bcr-2012-008388
- Vinjamoori, A.H., Jagannathan, J.P., Shinagare, A.B., Taplin, M.-E., Oh, W.K., Van den Abbeele, A.D., et al. (2012) Atypical Metastases from Prostate Cancer: 10-Year Experience at a Single Institution. AJR American Journal of Roentgenology, 199, 367-372. https://doi.org/10.2214/AJR.11.7533
- Long, M.A. and Husband, J.E. (1999) Features of Unusual Metastases from Prostate Cancer. The British Journal of Radiology, 72, 933-941. https://doi.org/10.1259/bjr.72.862.10673942
- Hayes, J.H. and Barry, M.J. (2014) Screening for Prostate Cancer with the Prostate-Specific Antigen Test: A Review of Current Evidence. JAMA, 311, 1143-1149. https://doi.org/10.1001/jama.2014.2085
- Moyer, V.A. and US Preventive Services Task Force (2012) Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 157, 120-134. https://doi.org/10.7326/0003-4819-157-2-201207170-00459
- Bibbins-Domingo, K., Grossman, D.C. and Curry, S.J. (2017) The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment. JAMA, 317, 1949-1950. https://doi.org/10.1001/jama.2017.4413
- Wu, A.J., Mehra, R., Hafez, K., Wolf, J.S. and Kunju, L.P. (2015) Metastases to the Kidney: A Clinicopathological Study of 43 Cases with an Emphasis on Deceptive Features. Histopathology, 66, 587-597. https://doi.org/10.1111/his.12524